GlaxoSmithKline is the world's leading research-based company whose mission is to improve the quality of human life by enabling people to do more, feel better, live longer.



With headquarters in the UK, GlaxoSmithKline was borne out of a merger by Glaxo Wellcome and SmithKline Beecham in January 8, 2001. It has an R&D investment of $4 billion a year, annual sales of over $26 billion and employs over 100,000 people worldwide.



As a global company committed to understanding and meeting the needs of its customers, the true strength of GlaxoSmithKline lies in it operating companies that are responsive to their unique local markets.





GLAXOSMITHKLINE PHILIPPINES



Glaxo SmithKline Philippines is the largest pharmaceutical company in the country with a market share of 14% and annual sales of over 7.5 billion pesos.



GlaxoSmithKline Philippines is the market leader in the areas of anti-infectives, respiratory, metabolic diseases and vaccines. The company stands on three strong pillars namely, the pharmaceuticals business, consumer healthcare, and nutraceuticals and vaccines. With the recent launch of breakthrough treatments for asthma, diabetes, Hepatitis B, hypertension and smoking cessation, the company has continued to dominate the pharmaceuticals market. Consumer healthcare (Aquafresh, Astring-a-sol, Eye-mo, Calpol, Dequadin and Mincee) is a fast growing business. Also growing rapidly are the nutraceutical products (Frisolac and Frisomel).



GlaxoSmithKline Philippines has always grown faster than the market over the past 16 years. This is due to the strength of its products and organization.

Pls call recruitment Hotline: 864-8511